Sobi boosts hematology sales with growth across key brands
16 Jul 2024 //
FIERCE PHARMA
Dova Announces DOPTELET® (avatrombopag) Data Presentations at Upcoming 62nd ASH
01 Dec 2020 //
PRNEWSWIRE
Dova Granted Orphan Drug Designation for Avatrombopag
13 Jan 2020 //
PR NEWSWIRE
Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag)
09 Dec 2019 //
PR NEWSWIRE
Sobi Successfully Completes Acquisition of Dova Pharmaceuticals
13 Nov 2019 //
BIOSPACE
Sobi finds another fit for its dealmaking strategy
01 Oct 2019 //
BIOPHARMADIVE
Can Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so
29 Jun 2019 //
FIERCE PHARMA
Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival
21 Nov 2018 //
FIERCE PHARMA